Are the Multiple Endocrine Neoplasia (MEN) syndromes inherited in an autosomal dominant pattern?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, the Multiple Endocrine Neoplasia (MEN) syndromes are autosomal dominant disorders. This means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition, and each child of an affected individual has a 50% chance of inheriting the mutation. There are several types of MEN syndromes, including MEN1 (caused by mutations in the MEN1 gene), MEN2A and MEN2B (both caused by mutations in the RET proto-oncogene), and MEN4 (caused by mutations in the CDKN1B gene) 1. These genetic mutations lead to the development of tumors in multiple endocrine glands, with each MEN type having characteristic patterns of tumor development. For example, MEN1 typically involves tumors of the parathyroid glands, pancreatic islet cells, and pituitary gland, while MEN2 syndromes commonly affect the thyroid (medullary thyroid cancer), adrenal glands (pheochromocytoma), and parathyroid glands.

Some key characteristics of the MEN syndromes include:

  • MEN1: caused by mutations in the MEN1 gene, typically involves tumors of the parathyroid glands, pancreatic islet cells, and pituitary gland
  • MEN2A and MEN2B: both caused by mutations in the RET proto-oncogene, commonly affect the thyroid, adrenal glands, and parathyroid glands
  • MEN4: caused by mutations in the CDKN1B gene, has a similar tumor spectrum to MEN1, but with a lower penetrance

Genetic testing is recommended for family members of affected individuals due to the autosomal dominant inheritance pattern 1. This allows for early identification of at-risk individuals and implementation of surveillance and preventive measures to reduce the risk of developing tumors and improving outcomes. The most recent and highest quality study 1 provides the strongest evidence for the autosomal dominant inheritance pattern of the MEN syndromes, and highlights the importance of genetic testing and surveillance in affected families.

From the Research

Inheritance Pattern of MEN Syndromes

  • The MEN syndromes exhibit an autosomal dominant pattern of inheritance 2, 3, 4, 5.
  • This means that a single copy of the mutated gene is enough to increase the risk of developing the condition.
  • The autosomal dominant inheritance pattern is characterized by a high degree of penetrance but varying expression 4.

Genetic Basis of MEN Syndromes

  • The genetic basis of MEN syndromes involves mutations in specific genes, such as the MEN1 gene and the RET gene 2, 5.
  • Mutations in the MEN1 gene are associated with MEN1, while mutations in the RET gene are associated with MEN2A, MEN2B, and familial medullary thyroid carcinoma (FMTC) 2.
  • Specific codon mutations within the RET gene correlate with disease phenotype and severity 2.

Clinical Implications of Autosomal Dominant Inheritance

  • The autosomal dominant inheritance pattern of MEN syndromes has important clinical implications, including the ability to identify asymptomatic patients who are at risk of developing the condition through genetic testing 3, 6.
  • Early detection and intervention can lead to a reduction in mortality and morbidity for MEN-associated tumors 6.
  • Prophylactic thyroidectomy can be performed in children who have inherited a mutated RET allele, preventing the development of medullary thyroid carcinoma (MTC) 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The multiple endocrine neoplasia syndromes.

Annual review of medicine, 2007

Research

Multiple endocrine neoplasia syndromes.

The Surgical clinics of North America, 2008

Research

Multiple endocrine neoplasia syndromes.

Critical reviews in oncology/hematology, 1984

Research

Multiple endocrine neoplasia (MEN) syndromes.

Seminars in pediatric surgery, 2014

Research

MEN syndromes.

Tumori, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.